|
|
Volumn 144, Issue 10, 2008, Pages 1402-1403
|
|
Eccrine squamous syringometaplasia secondary to pegylated liposomal doxorubicin
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIINFECTIVE AGENT;
BETAMETHASONE VALERATE;
BUSULFAN;
CARMUSTINE;
CISPLATIN;
CYCLOPHOSPHAMIDE;
CYTARABINE;
DOXORUBICIN;
ETOPOSIDE;
FLUOROURACIL;
MELPHALAN;
METHOTREXATE;
MITOXANTRONE;
PERMANGANATE POTASSIUM;
THIOTEPA;
ADULT;
ADVANCED CANCER;
ANTINEOPLASTIC ACTIVITY;
CANCER CHEMOTHERAPY;
CASE REPORT;
DISEASE ASSOCIATION;
DRUG DOSE REDUCTION;
DRUG ERUPTION;
DRUG FORMULATION;
ECCRINE SQUAMOUS SYRINGOMETAPLASIA;
ENDOMETRIOID CARCINOMA;
FEMALE;
GYNECOLOGIC CANCER;
HAND FOOT SYNDROME;
HISTOPATHOLOGY;
HUMAN;
HUMAN TISSUE;
LETTER;
PRIORITY JOURNAL;
SKIN BIOPSY;
SKIN DISEASE;
SKIN TOXICITY;
TREATMENT OUTCOME;
ADENOCARCINOMA;
ANTIBIOTICS, ANTINEOPLASTIC;
BIOPSY, NEEDLE;
DOXORUBICIN;
ECCRINE GLANDS;
ENDOMETRIAL NEOPLASMS;
ERYTHEMA;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
IMMUNOHISTOCHEMISTRY;
METAPLASIA;
MIDDLE AGED;
POLYETHYLENE GLYCOLS;
RISK ASSESSMENT;
SWEAT GLAND NEOPLASMS;
SYRINGOMA;
|
|
EID: 54349101491
PISSN: 0003987X
EISSN: 0003987X
Source Type: Journal
DOI: 10.1001/archderm.144.10.1402 Document Type: Letter |
|
Times cited : (9)
|
|
References (5)
|
